Disruptions in the Alzheimer’s Disease Market: The Impact of Razadyne's Genericization and the Launch of Biologic Disease-Modifying Drugs
This exclusive, in-depth webinar, presented by Therapeutic Area Director Andrea Witt, Ph.D., will be held on August 26, 2008 at 10 a.m. (EST). Because this presentation will feature major report findings, it is ONLY available to purchasers of the Physician & Payer Forum report, The Impact of Razadyne's Genericization and the Launch of Biologic Disease-Modifying Drugs on the Alzheimer's Disease Market: Clinician and Payer Receptivity to Novel Agents. Click here to learn how to purchase this report and attend this webinar.
Are Orphan Diseases an Entry Point to Larger Markets?
This webinar is based on our Orphan Disease Series reports, which provide critical market information for diseases with smaller patient populations, including disease prevalence, profiles of marketed and emerging agents and insight into the prescribing choices of disease specialists. Click here to access a playback of this event.
Opportunities for Emerging Disease-Modifying Therapies in Multiple Sclerosis
This webinar, based on our Treatment Algorithms in Multiple Sclerosis report, focuses on disease-modifying biologic drugs that gain the greatest patient shares in the earliest lines of therapy and key factors driving therapy choice among physicians. Click here to access a playback of this event.
Pharmaview Industry Outlook: Predictions for the Next 7 Years
Based on Decision Resources NEW Pharmaview product, this webinar will share the insight you need to understand how the pharmaceutical industry will evolve in the next 7 years. Click here to access a playback of this event.
Chronic Pain: Small Companies Devise Big Plans to Target Key Populations
This webinar, based on our Pharmacor report entitled Chronic Pain, focuses on a number of smaller companies that are investigating analgesics to treat chronic pain in eight key indications.
Click here to access a playback of this event.
Are the Glory Days of the U.S. Pharmaceutical Market in the Past? Pricing and Reimbursement Challenges Will Increase in the Years Ahead
This webinar, based on our Spectrum report, Pharmaceutical Pricing and Reimbursement in the United States, 2008 focuses on the affect of changing patterns of health insurance on the pharmaceutical industry; the impact of Medicare Part D on the U.S. prescription drug market; and many other issues currently facing the pharmaceutical industry.
Myth Busters: Physician Perceptions of Companies & Brands
This webinar, based on our 2007 Brands & Strategies Report Series, tests the conventional wisdom regarding physician opinions within the drug market against findings from our primary research with primary care physicians and specialists.
Obstacles and Opportunities in Cognitive Dysfunction: A Look at Cognitive Impairment Associated with Schizophrenia
This webinar, based on our recent Pharmacor report Cognitive Dysfunction, provides an overview of key issues in cognitive dysfunction, with a specific focus on the market for cognitive impairment associated with schizophrenia.
